If the strain was never found again, how is the 3 mg chip still cheap and available?
Write the price in the margin before the prize
Readers hunt a discovery myth. The useful margin is what the scoop cost the world later.
Most origin tales start with a genius and end with a medal. This one starts with a price. A 3 mg chip is cheap because the producing strain was a single isolate, the chemistry edit was small, and the first human market was a donation, not a boutique launch.
Adaeze's habit on this desk: write the hold, then the milligram, then the receipt. For history the hold is simpler than Loa. Do not romanticize dirt. Do not pretend a US pharmacy invented the bargain. The bargain was built in Tokyo plates, a New Jersey screen, and a 1987 pledge.
People still ask why generic Stromectol 3 mg sits on a low shelf. Because the molecule was never designed as a lifestyle tablet. It was designed as a microgram-per-kilogram tool. Small milligram, big weight math. Cheap follows that arithmetic if manufacturing stays honest.
File this next to the trial ledger in the virus-row note and the chip-count in the 200 mcg/kg count. History here is why those pages can talk about a 3 mg unit at all.
Kawana dirt never gave a second isolate
Satoshi Omura kept taking soil the way some people keep taking notes - on travel, near ordinary ground, not in a branded garden. Mid-1970s, Kawana on the Shizuoka coast, a golf-course verge. One scoop grew an uncatalogued Streptomyces later named Streptomyces avermitilis.
Every commercial 3 mg chip still descends from that isolate. Later surveys did not find the same organism again. That is not a poem. It is a supply fact. Global oncho and Strongyloides programs sit on culture stewardship of one strain.
Kitasato's real work was not the scoop. It was keeping the plate alive, scaling broth, and shipping something Merck could actually screen. Tokyo had fermentation craft. It did not have a barn full of parasitology models. Omura sent cultures instead of hoarding them.
Single-source luck makes people nervous. It should. A molecule this widely used still traces to one Japanese verge. The cheap 3 mg chip is not a weed you can re-harvest on any fairway. It is a lineage.
Merck paid for a mouse that almost died
Campbell's screen is the second half of the receipt. Without it the isolate stays a journal footnote.
Cultures crossed the Pacific into William Campbell's parasitology bench at Merck. The first interesting mouse almost died - oligomycin in the crude broth, a toxic Streptomyces leftover. Omura's group cleaned the culture. The next pass showed worm-killing at doses the host could live with.
Avermectins were the name on that hit. Campbell pushed the lead inside a company that could have killed it in committee. Most natural-product hits die that way. An advocate plus animal models is why you have a tablet and not a fermentation curiosity.
Split the credit the way the 2015 committee later did. Omura: organism and broth. Campbell: live-worm screen and development push. Neither side prices a 3 mg chip alone. Trans-Pacific mail in the 1970s was slow. The speed of the hit is still the surprising part.
If you want the molecule's present-tense pharmacology, open the labeled Stromectol page. This page stays on how that molecule became cheap enough to count.
Hydrogen at 22,23 is the cheapness edit
| Margin | Avermectin from the broth | Ivermectin in the chip |
|---|---|---|
| Who made it | Streptomyces avermitilis | Chemists after the isolate |
| The edit | None | Hydrogen at the 22,23 bond |
| What you can ship | A family of relatives | A 3 mg unit you can count |
| Why cheap later | Lead only | Stable enough for donation and generics |
Natural avermectin is not the tablet. Merck chemists added hydrogen across the 22,23 double bond and kept a mixture of two B1 forms. The edit made the scaffold more stable, a bit broader against worms, and easier to live with at a host dose.
That is why a 3 mg chip can sit in a blister for a mass campaign. Stability is a price story. A compound that falls apart in heat or light cannot be donated by the crate to a village store-room. Hydrogenation is a small chemical sentence with a large logistics clause.
Do not dress the edit as magic. It is ordinary medicinal chemistry: take a soil scaffold, file one bond, keep the kill, widen the margin. Same family of moves that turned other natural products into shippable drugs. The Nobel later named the scaffold. The warehouse named the tablet.
Animal sales paid for the human 3 mg
Ivomec and the rest of the veterinary line landed in the early 1980s - cattle, sheep, horses, dogs, heartworm prophylaxis. The animal product became a best-seller before any human label. That cash de-risked the human program.
People mix this chapter with the later horse-paste mess. Different objects. Veterinary success funded human trials. Veterinary paste sized for a 500 kg animal is not a human 3 mg chip. The first fact is history. The second is a poisoning pattern.
Human approval for onchocerciasis came in October 1987. Mohammed Aziz had already run the West Africa field work with WHO. Campbell suggested the human use. Aziz made the trials exist. He died the same year the donation was announced. The margin should keep his name.
A cheap human tablet is downstream of a profitable animal tablet. That is not a scandal. It is how the receipt actually runs. Pretending the 3 mg chip appeared as charity chemistry erases the barn that paid for it.
Vagelos priced river blindness at zero
1987 is the year the 3 mg unit stopped being a product and became a public-health currency.
Roy Vagelos, then Merck CEO, pledged Mectizan as much as needed, for as long as needed, for onchocerciasis. Not a five-year coupon. An open-ended donation. The Mectizan Donation Program, later run with the Task Force for Global Health in Atlanta, turned that sentence into crates.
Price at zero is why community-directed treatment could work. A village distributor can hand a 3 mg chip without negotiating a tender. Operational simplicity mattered as much as glutamate channels. Several countries later certified elimination of transmission. That is a price outcome.
Lymphatic filariasis later rode the same donation rails in combination regimens. The molecule did not become a vitamin. It became a campaign tablet. WHO still treats that campaign as a neglected-tropical-disease backbone - see WHO NTD pages.
US readers meet a different receipt: a generic 3 mg chip at a pharmacy counter. Same unit, different payer. Do not confuse Mectizan-at-zero with 'free on the internet.' Donation was for named programs. A US fill is still a prescription and a labeled indication.
A US generic 3 mg is a different receipt
Stromectol printed the US brand. The tablet strength on that label is 3 mg. Not a 6 mg novelty. Not a 12 mg souvenir. You count chips after micrograms per kilogram. Cheap in a US sense means generic 3 mg, not a made-up higher-strength tablet.
Pharmacy price and donation price are not the same sentence. Donation removed cost as a barrier in endemic zones. Generic competition later pulled the US cash price down. Both are true. Neither authorizes a cart on this desk.
People type cheap ivermectin 3 mg because the unit is small and the patent is old. Fair. The margin still says: cheap is not the same as indicated. A bargain chip for a named worm is a public-health win. A bargain chip for a virus headline is a category error - that fight lives in the crossed-out virus row.
If you are counting tablets tonight, leave this page. Open the weight-band count. History will not tell you whether you need four chips or five.
The 2015 medal did not rewrite the receipt
Mid-1970s
Omura isolates Streptomyces avermitilis from Kawana soil near a golf course.
c. 1975
Campbell's group at Merck finds avermectin activity after a cleaned culture.
Early 1980s
Edited ivermectin launches in animals and funds the human path.
Oct 1987
Human oncho approval; Vagelos pledges Mectizan as long as needed.
2015
Omura and Campbell share the Nobel - the price story was already old.
October 2015: Nobel Prize in Physiology or Medicine to Omura and Campbell for avermectins, shared in the same year with Tu Youyou for artemisinin. The committee waited for durable field proof. Four decades is a normal Nobel lag, not an insult.
Pairing a soil bacterium with a plant antimalarial in one year was a theme, not a merger. Two natural-product paths against neglected tropical disease. The medal did not add a viral indication. It did not change the 3 mg strength. It did not make horse paste a human dose.
What the medal did: it locked the discovery story in public memory so later hype could steal the glow. Adaeze's counter-margin is dull on purpose. The glow belongs to worms with the channel. The cheap 3 mg chip is a logistics win. Steal neither for a pandemic slogan.
File the scoop without opening a cart
Take the blotter home in one line. Kawana priced cheap ivermectin 3 mg because one isolate, one bond edit, veterinary cash, and a zero-price donation made a countable unit. The medal was late praise. The chip was already in the field.
Do not turn that line into a shopping list. This site does not fill bottles. Bring a named organism and a weight in kilograms to a clinician who can see you. The live label beats a library essay.
If the next reader only remembers golf-course dirt, they missed the receipt. Remember the 3 mg unit. Remember who set oncho at zero. Remember that cheap is a history of manufacturing and pledge - not a permission slip.
Reader mail
Reader questions on this article
Answered by Dr. Adaeze Nwankwo, MD · Infectious disease & parasitology
Nine readers wrote the margin after the scoop. Editorial names. I answer as teaching, not as your chart.
Because industry kept the original isolate in culture, not because anyone re-scooped Kawana. Fermentation from a banked strain is ordinary manufacturing. Re-isolation would have been a scientific curiosity. It was not required for supply. Cheap follows scale and an old patent, not a second golf-course miracle. If a plant lost the master culture, that would be a real shortage story. It has not been the story. Stewardship of one lineage is why a generic 3 mg chip still exists.
Why do you talk about price instead of the Nobel? Is that not the whole point of a history page?
The medal is easy to recite. The receipt is what changed villages. Vagelos priced oncho at zero in 1987. That pledge, not a 2015 speech, is why community distributors could hand a 3 mg chip without a tender fight. I keep the Nobel. I refuse to let it eat the logistics. Readers who only remember Stockholm miss why cheap ivermectin 3 mg is a public-health sentence and not a slogan.
Was the Japanese lab just lucky, or was the method the real invention?
Both, and the method matters more for teaching. Omura collected widely, cultured stubborn Streptomyces, and sent the promising fifty or so broths onward. Thousands of negatives sit under that one hit. Luck chose Kawana. Volume and craft made luck usable. A single lucky scoop without Kitasato fermentation and a Merck screen is a jar of dirt. I tell students to copy the habit, not the fairway.
If animals got the drug first, does that make the human 3 mg chip a leftover?
No. Veterinary launch paid the bill and proved antiparasitic punch in species with real worm burdens. Human development still needed Aziz's West Africa trials and a separate label. Leftover would mean they poured cattle product into people. They did not. They made a 3 mg human tablet and, later, a donation brand called Mectizan. The leftover problem is modern: people reading a horse tube as if it were Stromectol. That is misuse, not history.
Who actually decided the drug would be free for river blindness?
Merck leadership under Roy Vagelos, announced in 1987, after human approval. Campbell's lecture later called the response fast - less than a month after the label. The operational machine is the Mectizan Donation Program with the Task Force for Global Health, WHO, endemic ministries, and a long list of NGOs. One CEO sentence does not deliver crates. The sentence did set the price at zero for that indication, which is the rare part.
Is generic cheap 3 mg in the US the same program as Mectizan?
Different receipts. Mectizan donation is a named public-health channel for onchocerciasis and, in combinations, lymphatic filariasis. A US generic 3 mg fill is a pharmacy product for a labeled indication, usually Strongyloides in this country, sometimes oncho in a traveler. Same milligram unit. Different payer, different paperwork, different 'free.' Do not walk into a US counter expecting a village campaign price. And do not treat a campaign tablet as a souvenir.
What should I read if I care about whether the 3 mg chip works, not how it was priced?
Open the virus-row essay for how trials filed the ledger, and the count after 200 mcg/kg for how a clinician piles chips. The molecule page is Stromectol 3 mg. This history note will not dose you. It will only tell you why the unit is a 3 mg chip and why cheap is not an accident.
Does the hydrogenation story mean the bacterium already made the finished drug?
Close, not identical. The organism made avermectins. Chemists hydrogenated the 22,23 bond and kept a B1 mixture. That is why we say semi-synthetic. The cheapness comes from a small edit on a potent scaffold, not from inventing a new ring system on a whiteboard. Patients swallow the edited chip. Historians who say 'the dirt made ivermectin' are skipping a lab step that made the unit shippable.
I keep seeing people use this Nobel story to sell the tablet for anything. How do you shut that down without sounding like you hate the drug?
I do not hate the drug. I prescribe it for worms that have the channel. I shut the hype by separating three files: discovery, indication, dose. Discovery is Kawana plus Merck plus donation. Indication is Strongyloides at 200 mcg/kg and oncho at 150, plus a few off-label mite uses with trials. Dose is a 3 mg chip counted after kilograms. A Nobel does not move a virus into that second file. Praise the scoop. Keep the row honest.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.
Last Updated